Blog
3 Top Coronavirus Stocks to Buy in December
'Tis the season for... coronavirus stocks? Yep. With so much happening on the development and regulatory fronts, now's a great time to look at investing in coronavirus stocks.
But which stocks are
3 Great Dividend Stocks That Are Also Fantastic Growth Stocks
Some things truly are mutually exclusive. You can't jump in the water without getting wet. You can't flip a coin and get both heads and tails. But not everything that seems mutually exclusive
Looking for the Next Trade Desk? This Under-the-Radar Small-Cap Stock Could Be It
The Trade Desk (NASDAQ: TTD) has been one of the big winners on the stock market this year.
Shares of the cloud-based ad tech platform have more than tripled this year, and the stock is up nearly
Having a Baby in 2021? 4 Financial Moves to Make
Image source: Getty Images.
While it doesn't influence our opinions of products, we do receive compensation from partners whose offers appear here. We're on your side, always. See our full
5 Stocks That Can Skyrocket in a Biden Bull Market
In less than six weeks, President-elect Joe Biden will be sworn in as the 46th President of the United States. Although he's inheriting a pandemic and one of the steepest recessions the U.S. economy
Roblox IPO Postponed Into 2021
Online gaming hub Roblox filed to go public Nov. 19 and most recently updated its IPO prospectus on Dec. 1 with plans to go public before the end of the year. But now, Roblox will postpone its IPO
5 Tax Moves to Make Before 2020 Ends
Fortunately for all of us, 2020 will soon draw to a close. Before it does, though, it's probably a good idea to look at your personal tax situation and make sure you're at least considering what you
Here's the Hot Target for Multiple Myeloma Drugs
B-cell maturation antigen (BCMA) has become a hot target for treatments for multiple myeloma. In this video from Motley Fool Live, recorded on Dec. 7, Corinne Cardina, bureau chief of healthcare and
Watch Out bluebird bio, CRISPR Is on Your Heels
For many years bluebird bio (NASDAQ: BLUE) has been in the lead for developing a potential cure for beta thalassemia and sickle cell disease. But CRISPR Therapeutics (NASDAQ: CRSP) and its partner
Why the U.K. Beat the U.S. in Authorizing a COVID Vaccine
Last week, the United Kingdom became the first country to grant emergency use authorization for a COVID-19 vaccine. BNT162b2, the coronavirus vaccine developed by Pfizer (NYSE: PFE) and BioNTech
Is It Too Late to Save for Retirement?
Nearly half of baby boomers have nothing at all saved for retirement, according to a report from the Insured Retirement Institute. If you're behind on your savings, you're not alone.
Retirement can
These 3 Decisions Can Make or Break Your Retirement
Your financial situation as a retiree will have a major impact on whether you enjoy your later years or struggle through them. Fortunately, even if you're close to retirement, you can still make
Where Will Constellation Brands Be in 1 Year?
Constellation Brands (NYSE: STZ) (NYSE: STZ.B), one of the world's top producers of alcoholic beverages, is often considered a recession-resistant stock. However, the COVID-19 recession this year
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Reviewers at the Food and Drug Administration (FDA) are working overtime these days. On Friday, the agency issued a late-evening emergency use authorization for Pfizer (NYSE: PFE) and BioNTech's
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion
On Saturday morning, AstraZeneca (NASDAQ: AZN) announced an agreement to buy Alexion Pharmaceuticals (NASDAQ: ALXN) and its line of treatments for rare diseases for $39 billion in a combination of
These Americans Will Receive COVID Vaccines First
The first COVID-19 vaccines could soon be on the way. Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) hope to win FDA emergency use authorizations (EUA) for their coronavirus vaccines this month. But
Apple Finally Started Making Its In-House Modem Earlier This Year
Apple's (NASDAQ: AAPL) dreams of making a modem in-house have been an open secret for years. The company has been hiring modem engineers for quite some time, even expanding its physical presence in
The GE Business You've Never Heard Of: And Why It Really Matters
The head of General Electric's (NYSE: GE) digital business, Patrick Byrne, recently gave a fascinating presentation at the Credit Suisse Global Industrials Conference. The presentation put some
Maxed Out Your Retirement Plan? Here's Another Way to Build Long-Term Wealth
Many people struggle to contribute any money at all to an IRA or 401(k) plan. If you're currently maxing yours out, consider yourself ahead of the game. But what if you still have the financial
Forget Fuel Cells, Solar Is a Better Way to Invest in Renewable Energy
The rapid growth of renewables as an energy source has rightly caught investors' attention. Hydrogen fuel cells, in particular, have managed to garner phenomenal interest. Stocks of Plug Power
Confident That an Effective Coronavirus Vaccine is Coming? Consider These 3 ETFs
Coronavirus vaccines are in the news every day as people across the globe look for relief from both the deadly disease and the behavioral restrictions necessary to stem its spread. But now, with
Forget AT&T: This Telecom Is a Better Dividend Stock
AT&T (NYSE: T) has been a popular dividend stock for many years due to its relative stability, name recognition, and high yield. The company is a Dividend Aristocrat -- meaning that it has raised
Why Your Healthcare Costs as a Senior Could Be Higher Than Planned
When you're thinking about how you'll spend your money as a retiree, chances are good that one of the biggest expenses isn't even on your radar. It's the cost of healthcare, which more than
How to Raise Your Credit Score From "Poor" to "Good" by 2022
Image source: Getty Images.
While it doesn't influence our opinions of products, we do receive compensation from partners whose offers appear here. We're on your side, always. See our full
Why Stitch Fix Stock Is Soaring
In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Jason Moser about the latest headlines and earnings reports from Wall Street. They break down the numbers to see what's


